SOURCE: Targeted Genetics

March 12, 2008 19:01 ET

Targeted Genetics to Present at Invest Northwest Investor and CEO Forum 2008

SEATTLE, WA--(Marketwire - March 12, 2008) - Targeted Genetics Corporation (NASDAQ: TGEN) announced today that H. Stewart Parker, President and Chief Executive Officer, will present a company overview at the Invest Northwest™ Investor and CEO Forum on Tuesday, March 18, at 8:40 a.m. Pacific Time at the Bell Harbor International Conference Center in Seattle, WA.

The presentation will be webcast live and available for replay from the Targeted Genetics website, Links to connect can be found on the Company's homepage under the "Events" section.

About Targeted Genetics

Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at

Contact Information

  • Investor and Media Contacts:

    Stacie D. Byars
    WeissComm Partners for
    Targeted Genetics Corporation
    Email Contact

    Carolyn Wang
    WeissComm Partners
    Email Contact